Skip to main content
Top
Published in: International Journal of Hematology 4/2014

01-04-2014 | Original Article

Clinical features and underlying causes of cerebral venous thrombosis in Japanese patients

Authors: Akihiro Shindo, Hideo Wada, Hidehiro Ishikawa, Ai Ito, Masaru Asahi, Yuichiro Ii, Makoto Ikejiri, Hidekazu Tomimoto

Published in: International Journal of Hematology | Issue 4/2014

Login to get access

Abstract

The clinical symptoms, causative factors, and prognosis in Japanese patients with cerebral venous thrombosis have not been adequately characterized. The present study describes these features in patients in Japan. Twenty-two patients with cerebral venous thrombosis were retrospectively identified. Diagnosis was confirmed by either digital subtraction angiography, magnetic resonance venography, or contrast-enhanced computed tomography. Demographic data and clinical and radiological features were recorded and analyzed for each patient. Prognosis was evaluated by the modified Rankin scale (mRS) at the time of hospital discharge. The most frequent symptom of cerebral venous thrombosis was headache (59.1 %). Causative factors included congenital thrombophilia (31.8 %), acquired thrombophilia (27.3 %), and iron-deficiency anemia (13.6 %). Of seven patients with congenital thrombophilia, four had mutations in the protein S gene, two had mutations in the protein C gene, and one had mutations in the antithrombin gene. All patients were alive at discharge from hospital. Nineteen of the 22 patients (86.4 %) recovered completely or exhibited only mild residual symptoms (mRS 0–2). However, three patients (13.6 %) had a poor prognosis (mRS 3–5). Cerebral venous thrombosis in Japanese patients is frequently associated with congenital thrombophilia and protein S gene mutation.
Literature
1.
go back to reference Guenther G, Arauz A. Cerebral venous thrombosis: a diagnostic and treatment update. Neurologia. 2011;26:488–98.PubMedCrossRef Guenther G, Arauz A. Cerebral venous thrombosis: a diagnostic and treatment update. Neurologia. 2011;26:488–98.PubMedCrossRef
2.
3.
go back to reference Ameri A, Bousser MG. Cerebral venous thrombosis. Neurol Clin. 1992;10:87–111.PubMed Ameri A, Bousser MG. Cerebral venous thrombosis. Neurol Clin. 1992;10:87–111.PubMed
4.
go back to reference Ogata T, Kamouchi M, Kitazono T, Kuroda J, Ooboshi H, Shono T, et al. Cerebral venous thrombosis associated with iron deficiency anemia. J Stroke Cerebrovasc Dis. 2008;17:426–8.PubMedCrossRef Ogata T, Kamouchi M, Kitazono T, Kuroda J, Ooboshi H, Shono T, et al. Cerebral venous thrombosis associated with iron deficiency anemia. J Stroke Cerebrovasc Dis. 2008;17:426–8.PubMedCrossRef
5.
go back to reference Shindo A, Ikejiri M, Ii Y, Nakatani K, Wada H, Nobori T, et al. A novel protein S gene mutation combined with protein S Tokushima mutation in a patient with superior sagittal sinus thrombosis. J Neurol. 2012;259:178–9.PubMedCrossRef Shindo A, Ikejiri M, Ii Y, Nakatani K, Wada H, Nobori T, et al. A novel protein S gene mutation combined with protein S Tokushima mutation in a patient with superior sagittal sinus thrombosis. J Neurol. 2012;259:178–9.PubMedCrossRef
6.
go back to reference Ikejiri M, Shindo A, Ii Y, Tomimoto H, Yamada N, Matsumoto T, et al. Frequent association of thrombophilia in cerebral venous sinus thrombosis. Int J Hematol. 2012;95:257–62.PubMedCrossRef Ikejiri M, Shindo A, Ii Y, Tomimoto H, Yamada N, Matsumoto T, et al. Frequent association of thrombophilia in cerebral venous sinus thrombosis. Int J Hematol. 2012;95:257–62.PubMedCrossRef
7.
go back to reference Yoshikawa T, Abe O, Tsuchiya K, Okubo T, Tobe K, Masumoto T, et al. Diffusion-weighted magnetic resonance imaging of dural sinus thrombosis. Neuroradiology. 2002;44:481–8.PubMedCrossRef Yoshikawa T, Abe O, Tsuchiya K, Okubo T, Tobe K, Masumoto T, et al. Diffusion-weighted magnetic resonance imaging of dural sinus thrombosis. Neuroradiology. 2002;44:481–8.PubMedCrossRef
8.
go back to reference Van Swieten JC, Koudstall PJ, Visser MC, Shouten HJ, van Gijn J. Interobserver agreement for the assessment of handicap in stroke patients. Stroke. 1989;19:604–7.CrossRef Van Swieten JC, Koudstall PJ, Visser MC, Shouten HJ, van Gijn J. Interobserver agreement for the assessment of handicap in stroke patients. Stroke. 1989;19:604–7.CrossRef
9.
go back to reference Ikejiri M, Tsuji A, Wada H, Sakamoto Y, Nishioka J, Ota S, et al. Analysis three abnormal protein S genes in a patient with pulmonary embolism. Thromb Res. 2010;125:529–32.PubMedCrossRef Ikejiri M, Tsuji A, Wada H, Sakamoto Y, Nishioka J, Ota S, et al. Analysis three abnormal protein S genes in a patient with pulmonary embolism. Thromb Res. 2010;125:529–32.PubMedCrossRef
10.
go back to reference Miyakis S, Lockshin MD, Atsumi T, Branch DW, Brey RL, Cervera R, et al. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost. 2006;4:295–306.PubMedCrossRef Miyakis S, Lockshin MD, Atsumi T, Branch DW, Brey RL, Cervera R, et al. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost. 2006;4:295–306.PubMedCrossRef
11.
go back to reference Teasdale G, Jannett B. Assessment of coma and impaired consciousness: a practical scale. Lancet. 1974;2:81.PubMedCrossRef Teasdale G, Jannett B. Assessment of coma and impaired consciousness: a practical scale. Lancet. 1974;2:81.PubMedCrossRef
12.
go back to reference Ferro JM, Canhão P, Stam J, Bousser MG, Barinagarrementeria F, for the ISCVT Investigators. Prognosis of cerebral vein and dural sinus thrombosis: results of the International Study on Cerebral Vein and Dural Sinus Thrombosis (ISCVT). Stroke. 2004;35:664–70.PubMedCrossRef Ferro JM, Canhão P, Stam J, Bousser MG, Barinagarrementeria F, for the ISCVT Investigators. Prognosis of cerebral vein and dural sinus thrombosis: results of the International Study on Cerebral Vein and Dural Sinus Thrombosis (ISCVT). Stroke. 2004;35:664–70.PubMedCrossRef
13.
go back to reference Canhão P, Ferro JM, Lindgren AG, Bousser MG, Stam J, Barinagarrementaria F, for the ISCVT Investigators. Causes and predictors of death in cerebral venous thrombosis. Stroke. 2005;36:1720–5.PubMedCrossRef Canhão P, Ferro JM, Lindgren AG, Bousser MG, Stam J, Barinagarrementaria F, for the ISCVT Investigators. Causes and predictors of death in cerebral venous thrombosis. Stroke. 2005;36:1720–5.PubMedCrossRef
14.
go back to reference Ferro JM, Canhão P, Bousser MG, Stam J, Barinagarrementeria F, for the ISCVT Investigators. Cerebral vein and dural sinus thrombosis in elderly patients. Stroke. 2005;36:1927–32.PubMedCrossRef Ferro JM, Canhão P, Bousser MG, Stam J, Barinagarrementeria F, for the ISCVT Investigators. Cerebral vein and dural sinus thrombosis in elderly patients. Stroke. 2005;36:1927–32.PubMedCrossRef
15.
go back to reference Ferro JM, Lopes MG, Rosas MJ, Ferro MA, Fontes J, for the Cerebral Venous Thrombosis Portuguese Collaborative Study Group. Long-term prognosis of cerebral vein and dural sinus thrombosis: results of the VENOPORT study. Cerebrovasc Dis. 2002;13:272–8.PubMedCrossRef Ferro JM, Lopes MG, Rosas MJ, Ferro MA, Fontes J, for the Cerebral Venous Thrombosis Portuguese Collaborative Study Group. Long-term prognosis of cerebral vein and dural sinus thrombosis: results of the VENOPORT study. Cerebrovasc Dis. 2002;13:272–8.PubMedCrossRef
16.
17.
go back to reference Simchen MJ, Goldstein G, Lubetsky A, Strauss T, Schiff E, Kenet G. Factor v Leiden and antiphospholipid antibodies in either mothers or infants increase the risk for perinatal arterial ischemic stroke. Stroke. 2009;40:65–70.PubMedCrossRef Simchen MJ, Goldstein G, Lubetsky A, Strauss T, Schiff E, Kenet G. Factor v Leiden and antiphospholipid antibodies in either mothers or infants increase the risk for perinatal arterial ischemic stroke. Stroke. 2009;40:65–70.PubMedCrossRef
18.
go back to reference Berkun Y, Padeh S, Barash J, Uziel Y, Harel L, Mukamel M, et al. Antiphospholipid syndrome and recurrent thrombosis in children. Arthritis Rheum. 2006;55:850–5.PubMedCrossRef Berkun Y, Padeh S, Barash J, Uziel Y, Harel L, Mukamel M, et al. Antiphospholipid syndrome and recurrent thrombosis in children. Arthritis Rheum. 2006;55:850–5.PubMedCrossRef
19.
go back to reference Kottke-Marchant K, Duncan A. Antithrombin deficiency: issues in laboratory diagnosis. Arch Pathol Lab Med. 2002;126:1326–36.PubMed Kottke-Marchant K, Duncan A. Antithrombin deficiency: issues in laboratory diagnosis. Arch Pathol Lab Med. 2002;126:1326–36.PubMed
20.
go back to reference Dahlbäck B. The protein C anticoagulant system: inherited defects as basis for venous thrombosis. Thromb Res. 1995;77:1–43.PubMedCrossRef Dahlbäck B. The protein C anticoagulant system: inherited defects as basis for venous thrombosis. Thromb Res. 1995;77:1–43.PubMedCrossRef
21.
go back to reference Beauchamp NJ, Dykes AC, Parikh N, Campbell Tait R, Daly ME. The prevalence of, and molecular defects underlying, inherited protein S deficiency in the general population. Br J Haematol. 2004;125:647–54.PubMedCrossRef Beauchamp NJ, Dykes AC, Parikh N, Campbell Tait R, Daly ME. The prevalence of, and molecular defects underlying, inherited protein S deficiency in the general population. Br J Haematol. 2004;125:647–54.PubMedCrossRef
23.
go back to reference Segers K, Dhalbäck B, Nicolaes GA. Coagulation factor V and thrombophilia: background and mechanisms. Thromb Haemost. 2007;98:530–42.PubMed Segers K, Dhalbäck B, Nicolaes GA. Coagulation factor V and thrombophilia: background and mechanisms. Thromb Haemost. 2007;98:530–42.PubMed
24.
go back to reference Vicente V, González-Conejero R, Rivera J, Corral J. The prothrombin gene variant 20210A in venous and arterial thromboembolism. Haematologica. 1999;84:356–62.PubMed Vicente V, González-Conejero R, Rivera J, Corral J. The prothrombin gene variant 20210A in venous and arterial thromboembolism. Haematologica. 1999;84:356–62.PubMed
25.
go back to reference Bombeli T, Basic A, Fehr J. Prevalence of hereditary thrombophilia in patients with thrombosis in different venous systems. Am J Hematol. 2002;70:126–32.PubMedCrossRef Bombeli T, Basic A, Fehr J. Prevalence of hereditary thrombophilia in patients with thrombosis in different venous systems. Am J Hematol. 2002;70:126–32.PubMedCrossRef
26.
go back to reference Takamiya O, Ishida F, Kodaira H, Kitano K. APC-resistance and Mnl I genotype (Gln 506) of coagulation factor V are rare in Japanese population. Thromb Haemost. 1995;74:996.PubMed Takamiya O, Ishida F, Kodaira H, Kitano K. APC-resistance and Mnl I genotype (Gln 506) of coagulation factor V are rare in Japanese population. Thromb Haemost. 1995;74:996.PubMed
27.
go back to reference Miyata T, Kimura R, Kokubo Y, Sakata T. Genetic risk factors for deep vein thrombosis among Japanese: importance of protein S K196E mutation. Int J Hematol. 2006;83:217–23.PubMedCrossRef Miyata T, Kimura R, Kokubo Y, Sakata T. Genetic risk factors for deep vein thrombosis among Japanese: importance of protein S K196E mutation. Int J Hematol. 2006;83:217–23.PubMedCrossRef
28.
go back to reference Kimura K, Honda S, Kawasaki T, Tsuji H, Madoiwa S, Sakata Y, et al. Protein S-K196E mutation as a genetic risk factor for deep vein thrombosis in Japanese patients. Blood. 2006;107:1737–8.PubMedCrossRef Kimura K, Honda S, Kawasaki T, Tsuji H, Madoiwa S, Sakata Y, et al. Protein S-K196E mutation as a genetic risk factor for deep vein thrombosis in Japanese patients. Blood. 2006;107:1737–8.PubMedCrossRef
29.
go back to reference Neki R, Fujita T, Kokame K, Nakanishi I, Waguri M, Imayoshi Y, et al. Genetic analysis of patients with deep vein thrombosis during pregnancy and postpartum. Int J Hematol. 2011;94:150–5.PubMedCrossRef Neki R, Fujita T, Kokame K, Nakanishi I, Waguri M, Imayoshi Y, et al. Genetic analysis of patients with deep vein thrombosis during pregnancy and postpartum. Int J Hematol. 2011;94:150–5.PubMedCrossRef
30.
go back to reference Sato R, Iwasawa M. Contraceptive use and induced abortion in Japan: how is it so unique among the developed countries? Jpn J Popul. 2006;4:33–54. Sato R, Iwasawa M. Contraceptive use and induced abortion in Japan: how is it so unique among the developed countries? Jpn J Popul. 2006;4:33–54.
31.
go back to reference Khealani BA, Wasay M, Saadah M, Sultana E, Mustafa S, Khan FS, et al. Cerebral venous thrombosis: a descriptive multicenter study of patients in Pakistan and Middle East. Stroke. 2008;39:2707–11.PubMedCrossRef Khealani BA, Wasay M, Saadah M, Sultana E, Mustafa S, Khan FS, et al. Cerebral venous thrombosis: a descriptive multicenter study of patients in Pakistan and Middle East. Stroke. 2008;39:2707–11.PubMedCrossRef
Metadata
Title
Clinical features and underlying causes of cerebral venous thrombosis in Japanese patients
Authors
Akihiro Shindo
Hideo Wada
Hidehiro Ishikawa
Ai Ito
Masaru Asahi
Yuichiro Ii
Makoto Ikejiri
Hidekazu Tomimoto
Publication date
01-04-2014
Publisher
Springer Japan
Published in
International Journal of Hematology / Issue 4/2014
Print ISSN: 0925-5710
Electronic ISSN: 1865-3774
DOI
https://doi.org/10.1007/s12185-014-1550-x

Other articles of this Issue 4/2014

International Journal of Hematology 4/2014 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine